PPARG and atherosclerosis: Since the M1 macrophages express the receptor of oxidized low-density lipoproteins (CD68), mediating their influx to the foam cells [106], shifting the differentiation of macrophages toward the M2 phenotype could partially explain the beneficial effects of PPAR-γ agonists in psoriasis patients with atherosclerosis.